Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Rahman syndrome is characterized by mild to severe intellectual disability associated with variable somatic overgrowth manifest as increased birth length, height, weight, and/or head circumference. The overgrowth is apparent in infancy and may lessen with time or persist. The phenotype is highly variable; some individuals may have other minor anomalies, including dysmorphic facial features, strabismus, or camptodactyly. The disorder is thought to result from a defect in epigenetic regulation (summary by {1:Tatton-Brown et al., 2017}).
Features include always present findings: Intellectual disability, Full cheeks, Global developmental delay, and High anterior hairline and others; and common findings: Feeding difficulties and Neonatal hypotonia. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Anxiety, Enlarged brain ventricles (ventriculomegaly), Intellectual disability |
H1-4 encodes H1.4 linker histone, cluster member (219 aa). Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Highest expression in Vagina (3.9 TPM) and Breast Mammary Tissue (3.3 TPM).
Rahman syndrome is associated with mutations in the H1-4 gene on chromosome 6.
H1-4 is classified as a druggable target (Clinically Actionable and Druggable Genome categories) with score 0.0.
No consensus clinical diagnostic criteria for HIST1H1E syndrome have been published.
HIST1H1E syndrome should be considered in individuals with the following clinical findings [, , , , ]. Clinical findings include mild-to-profound developmental delay or intellectual disability AND a combination of the following features presenting in infancy or childhood:
Source: GeneReviews — "HIST1H1E Syndrome"
No approved treatments are currently available for Rahman syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for HIST1H1E syndrome have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with HIST1H1E syndrome, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 3. Recommended Evaluations Following Initial Diagnosis in Individuals with HIST1H1E Syndrome
Table 5. Recommended Surveillance for Individuals with HIST1H1E Syndrome
System/Concern |
|---|
No clinical trials have been registered for Rahman syndrome.
26 publications have been identified in PubMed for Rahman syndrome. Research spans Case Report / Case Series (50%), Basic Science / Preclinical (27%), and Other (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 50% |
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 11:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Rahman syndrome
Eyes |
2 |
Strabismus, Amblyopia |
Digestive system | 2 | Chronic constipation, Feeding difficulties |
Bones and joints | 2 | Kyphoscoliosis, Accelerated skeletal maturation |
Head and neck | 1 | Macrocephaly |
Skin | 1 | Redundant skin |
Muscles | 1 | Neonatal hypotonia |
Pregnancy and birth | 1 | Neonatal hypotonia |
Age of onset: newborn period.
HIST1H1E syndrome is characterized by intellectual disability and a distinctive facial gestalt [, Figure 3]. To date, 47 individuals have been identified with a heterozygous pathogenic variant in H1-4 (formerly HIST1H1E). provides data on the phenotypic features of 46 affected individuals in four studies and two case reports [, , , , , ]. Because the earliest identified published report of an individual with a H1-4 pathogenic variant mentioned "Sotos syndrome-like features" and autism spectrum disorder, but no other clinical information , it was not included in this tabulation.
Table 2.
Features of HIST1H1E Syndrome
Feature | Proportion of Persons w/Feature | Comment
Cognition motor development | 100% (46/46) | ID is highly variable, ranging from mild to severe.
Source: GeneReviews — "HIST1H1E Syndrome"
No genotype-phenotype correlations have been identified.
Source: GeneReviews — "HIST1H1E Syndrome"
Data are currently insufficient to determine the penetrance of H1-4 germline pathogenic variants
Source: GeneReviews — "HIST1H1E Syndrome"
All disorders with intellectual disability without other distinctive findings should be considered in the differential diagnosis of HIST1H1E syndrome. See OMIM Autosomal Dominant, Autosomal Recessive, Nonsyndromic X-Linked, and Syndromic X-Linked Intellectual Developmental Disorder Phenotypic Series. While it has previously been suggested that HIST1H1E syndrome belongs to the family of overgrowth-intellectual disability syndromes , recent data suggest that most children with HIST1H1E syndrome do not have tall stature or macrocephaly .
Source: GeneReviews — "HIST1H1E Syndrome"
Genetic testing for H1-4 is available. Testing is considered confirmatory for diagnosis.
System/Concern | Evaluation | Comment |
|---|---|---|
Development | Developmental assessment | To incl:; Motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education |
Behavior | Neuropsychiatric eval | For persons age 12 mos: evaluate for behavior concerns incl sleep disturbances, ADHD, anxiety, /or findings suggestive of ASD. |
Neurologic | Neurologic eval | EEG if seizures are a concern; Consider brain MRI if there are focal neurologic findings. |
Genitourinary | Examine males for cryptorchidism. | If present, referral to pediatric urologist. |
Cardiovascular | Echocardiogram | To evaluate for structural cardiac anomalies |
Endocrine | TSH T4 | To evaluate for hypothyroidism Skeletal |
abnormalities | Assessment of head shape for sutural ridging in infants | If abnormal, consider head CT w/3D reconstruction to assess for craniosynostosis. Physical exam to assess for evidence of scoliosis |
dentition | Dental eval to assess for caries, evidence of thin enamel, hypodontia | Panorex may be considered if hypodontia is suspected |
Eyes | Ophthalmology eval | To assess for strabismus, refractive error Genetic |
counseling | By genetics professionals1 | To inform persons their families re nature, MOI, implications of HIST1H1E syndrome to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with HIST1H1E Syndrome Manifestation/Concern | Treatment | Considerations/Other Developmental delay / |
Intellectual disability | See . | — |
Behavioral | Behavioral mgmt strategies consideration of medication to treat ADHD | In consultation w/developmental pediatrician or psychiatrist |
Seizures | Standardized treatment w/ASMs by experienced neurologist | Education of parents/caregivers1 |
Cryptorchidism in males | Standard treatment per urologist | — |
Congenital heart defects | Standard treatment per cardiologist | — |
Hypothyroidism | Thyroid hormone replacement per endocrinologist | — |
Craniosynostosis | Standard treatment, ideally through a craniofacial center | Treating physicians may incl neurosurgeons plastic surgeons. |
Scoliosis | Standard treatment per orthopedist | Decreased bone mineral density |
Abnormal dentition | By a pediatric dentist specializing in care of children w/neurodevelopmental disorders /or enamel hypoplasia | When possible |
Hearing loss | Hearing aids may be helpful; per otolaryngologist. | Community hearing services through early intervention or school district; if conductive hearing loss, pressure-equalizing tube placement could be considered. Strabismus / |
Refractive error | Standard treatment per ophthalmologist | Family/Community |
Source: GeneReviews — "HIST1H1E Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "HIST1H1E Syndrome"
View trials for Rahman syndrome
Evaluation
Frequency |
|---|
Development | Monitor developmental progress educational needs. | At each visit Psychiatric/ |
Dental | Dental eval | Every 6 mos, starting at age ~2-3 yrs |
Ears/Hearing | Assessment for frequent otitis media | At each visit Audiology eval |
Endocrine | Thyroid function studies to incl TSH free T4 | Annually |
Eyes | Ophthalmology eval | Annually or as clinically indicated Miscellaneous/ |
Other | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination. | At each visit Reevaluation by a clinical geneticist for new developments /or recommendations |
Source: GeneReviews — "HIST1H1E Syndrome"
Phenotype severity distribution: 5 always present features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
7 |
27% |
Other research | 2 | 8% |
Research summaries | 2 | 8% |
Disease patterns and progression | 2 | 8% |
Barakat N (2026). [PMID: 41358577](https://pubmed.ncbi.nlm.nih.gov/41358577/). *Am J Med Genet A*. [Case Report / Case Series]
Ghulman RR (2026). [PMID: 42181528](https://pubmed.ncbi.nlm.nih.gov/42181528/). *Case Rep Dent*. [Case Report / Case Series]
Datta AN (2026). [PMID: 41854408](https://pubmed.ncbi.nlm.nih.gov/41854408/). *Epileptic Disord*. [Case Report / Case Series]
Boopathi R (2026). [PMID: 42173878](https://pubmed.ncbi.nlm.nih.gov/42173878/). *Nat Commun*. [Basic Science / Preclinical]
Mehta SG (2026). [PMID: 41741684](https://pubmed.ncbi.nlm.nih.gov/41741684/). *Eur J Hum Genet*. [Case Report / Case Series]
Ferreira L (2026). [PMID: 41764803](https://pubmed.ncbi.nlm.nih.gov/41764803/). *Cancer Genet*. [Case Report / Case Series]
Das S (2026). [PMID: 41518027](https://pubmed.ncbi.nlm.nih.gov/41518027/). *Pediatr Blood Cancer*. [Other]
Atterton C (2025). [PMID: 40353642](https://pubmed.ncbi.nlm.nih.gov/40353642/). *Dis Model Mech*. [Review / Meta-Analysis]
Wheeler MES (2025). [PMID: 41456056](https://pubmed.ncbi.nlm.nih.gov/41456056/). *Epigenetics Chromatin*. [Basic Science / Preclinical]
Le Collen L (2025). [PMID: 39734048](https://pubmed.ncbi.nlm.nih.gov/39734048/). *Ann Endocrinol (Paris)*. [Case Report / Case Series]